Consistent with these findings, neutralization of TGF-β signaling in the TME was found to impair liver metastasis establishment by unleashing T cell and NK cells anti-tumor responses, in different pre-clinical CRC models (14, 40, 54, 55, 58, 62). This evidence concerns the gene TGFB1 and neoplasm.